Dyne Therapeutics Overview
Dyne Therapeutics Target Price
Analysts' 12-month price predictions for DYN.
Share Price
$11.41
Average Target Price
$47.00
311.9% upside
311.9% upside2 analysts in the last 4 months
High: $48 | Low: $46
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-02-28 | UBS | $48 | 320.7% upside |  |
| 2025-02-28 | H.C. Wainwright | $46 | 303.2% upside | |
| 2024-08-14 | Morgan StanleyMichael Ulz | $52 | 355.7% upside | |
| 2024-08-13 | Piper SandlerEdward Tenthoff | $53 | 364.5% upside | |
| 2024-06-24 | JefferiesEun Yang | $42 | 268.1% upside | |
| 2024-06-17 | OppenheimerFrancois Brisebois | $55 | 382% upside | |
| 2024-05-21 | Chardan CapitalKeay Nakae | $42 | 268.1% upside | |
| 2024-05-20 | H.C. WainwrightAndrew Fein | $48 | 320.7% upside | |
| 2024-05-20 | Stifel NicolausPaul Matteis | $41 | 259.3% upside | |
| 2024-04-30 | Morgan StanleyMichael Ulz | $40 | 250.6% upside | |
| 2022-11-29 | J.P. Morgan | $18 | 57.8% upside | |
| 2022-09-06 | Piper SandlerEdward Tenthoff | $23 | 101.6% upside | |
| 2022-07-12 | Piper SandlerEdward Tenthoff | $17 | 49% upside | |